Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# EBS: FDA Approves NARCAN® Multipacks—Act Now! ## Overview Emergent BioSolutions (NYSE: **EBS**) is a specialty biopharma company focused on public health threats and…
Read more# Citigroup (C): Next Move After Orchestra BioMed’s “Grant” – What’s Ahead? ## Company Overview and Context Citigroup Inc. (NYSE: C) is one of the world’s largest banks, with a…
Read more# NGEN: CFO Retirement Sparks New Strategic Opportunities! ## Company Overview and CFO Transition NervGen Pharma Corp.
Read more# VTGN Investors: Class Action Info for Major Losses!
Read more# EDSA’s 1Q 2026 Results: What You Need to Know Now! ## Company Overview & 1Q 2026 Highlights **Edesa Biotech (NASDAQ: EDSA)** is a clinical-stage biotech focused on…
Read more# CHRS: Don't Miss Coherus' Key Stock Offering Update! ## Recent Stock Offering & Strategic Overview Coherus BioSciences (now **Coherus Oncology**, NASDAQ: CHRS) recently executed…
Read more# NGEN: Major Shift as CFO Bill Adams Retires! **Overview:** NervGen Pharma Corp. (TSXV/NASDAQ: **NGEN**) is a Vancouver-based clinical-stage biotech developing neuroreparative…
Read more# PROF: Don't Miss Q4 Results on March 5th! ## Company Overview and Q4 Earnings Preview **Profound Medical Corp.
Read more# F5 (FFIV): Scrutiny Over Alleged Long-Term Hack! **F5, Inc. (NASDAQ: FFIV)** is a Seattle-based technology company known for its application delivery controllers and security…
Read more# VTGN: Act Now on Securities Violations Before March 16! ## Overview VistaGen Therapeutics (NASDAQ: **VTGN**) is a late-stage biotech whose stock has been on a rollercoaster due…
Read more# Don't Miss Out: MREO Investors Contact Levi & Korsinsky! ## Introduction Mereo BioPharma Group plc (NASDAQ: **MREO**) – a UK-based rare-disease biotech – is under intense…
Read more# NCI: NIH to study ivermectin's cancer potential! ## Company Overview **Neo-Concept International Group Holdings (NASDAQ: NCI)** is a Hong Kong-based provider of one-stop apparel…
Read more# EBS: FDA Approval for NARCAN® Multipacks Sparks Surge!
Read more# CHRS: Don’t Miss Coherus’ Public Offering Opportunity! ## Company Overview and Recent Developments Coherus Oncology, Inc. (NASDAQ: CHRS), formerly Coherus BioSciences, is a U.S.
Read moreCompany Overview & Recent Developments AppLovin Corporation (NASDAQ: APP) is a marketing software platform that provides software and AI solutions for mobile app developers to…
Read more# HUBG Alert: Contact Kirby McInerney on Potential Violations! ## Company Overview and Recent Developments **Hub Group, Inc.
Read more# BRTX: Don’t Miss $5M Public Offering Opportunity! ## Company Overview BioRestorative Therapies, Inc.
Read more# OKYO: Major Equity Transition to Leerink Partners!
Read more# PDT: FDA Filing Boosts Ameluz® for Skin Cancer Treatment! **Company Overview:** Biofrontera Inc. (NASDAQ: BFRI) is a U.S.-based biopharmaceutical company focused on dermatology,…
Read more# MYRG: Earnings Call Ahead—Don't Miss Key Insights! ## Introduction MYR Group Inc.
Read more
